Regulation of gastrointestinal hormone signaling and metabolism by Neuromedin U
Regulation of gastrointestinal hormone signaling and metabolism by Neuromedin U
批准号:
9461525
负责人:
Seung K Kim
金额:
$39.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-01 至 2022-03-31
关键词:
AcuteAddressAllelesBeta CellBiologyBody mass indexCellsColonComorbidityCoupledDiabetes MellitusDiagnosisDiseaseDrosophila genusDrosophila melanogasterDuodenumElectrophysiology (science)ElementsEndocrineEnteralEnterobacteria phage P1 Cre recombinaseEnteroendocrine CellEquilibriumFoundationsG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGalaninGap JunctionsGastric BypassGastrointestinal HormonesGastrointestinal tract structureGenesGeneticGlucagonGlucoseHealthHomeostasisHormonesHumanHyperglycemiaHyperinsulinismIn VitroInsulinIntestinal HormonesIntestinesInvestigationIslet CellIslets of LangerhansLigandsLinkLipidsMammalsMetabolicMetabolic ControlMetabolismMethodsMolecularMouse StrainsMusMutant Strains MiceMutationNeuromedin UNon-Insulin-Dependent Diabetes MellitusNutrientObesityOperative Surgical ProceduresOrganOrgan Culture TechniquesOutputPancreasPathway interactionsPeripheralPertussis ToxinPhysiologicalPrediabetes syndromeProductionRegulationResponse ElementsRiskRoleSignal PathwaySignal TransductionSomatostatinSourceStomachTestingTissuesWorkbariatric surgerybaseblood glucose regulationeffective therapygastrointestinalhormonal signalshormone metabolismileumimpaired glucose tolerancein vivoinnovationinsightinsulin secretionisletneuromedin U receptornovelnovel strategiespancreatic juicepeptide hormonereceptorresponserestorationtype I and type II diabetes
中文摘要
摘要
在肥胖症和2型糖尿病(T2 D)中,多激素失调可导致相对的
胰岛素缺乏状态。间接证据最近积累了肠道激素(称为decretin)
抑制胰岛素并增强胰高血糖素输出以促进T2 D。这是该领域的一个根本性进步
将鉴定正常调节胰岛素和胰高血糖素产生的天然激素,
由胰岛细胞分泌。我们最近发现了一种肠内分泌decretin信号通路,
果蝇Drosophila melanogaster受营养物质利用率调节,对脂质、葡萄糖和胰岛素至关重要
平衡我们从体外研究中证明,哺乳动物肽激素神经介肽U(Nmu)
与其同源的G蛋白偶联受体Nmu受体1(NmuR 1)具有相似的功能。恩穆群岛
产生于肠内分泌细胞,集中在胃、十二指肠和回肠。在本提案中,我们
概述了几种新颖的方法来研究配体-受体对Nmu/NmuR 1如何调节
胃肠激素分泌
为了在小鼠和人类中解决这些基本问题,我们提出了具体目标:1。
评估小鼠代谢稳态对肠Nmu的需求。2.解码Nmu信号转导
胰岛中G蛋白和NmuR 1的作用机制。3.确定调节NMU信号传导的机制
人胰岛中
这项建议也是值得注意的技术创新,在每个目标,包括建设多个新的
小鼠品系,以及使用新的ELISA来研究小鼠和人类中的Nmu调节。总的来说,这些
最先进的方法将产生对细胞和分子机制的重大新见解
在生理环境中控制代谢的肠内分泌调节。从根本上说,我们的工作
应该建立相互联系的代谢信号和关键的调控模式,
胃肠激素因此,我们的工作应该有广泛的影响,建议战略诊断,
分层风险,并治疗糖尿病或重要糖尿病前期疾病(如肥胖症)患者亚群
和葡萄糖耐量受损。
英文摘要
ABSTRACT
In obesity and type 2 diabetes mellitus (T2D), polyhormonal dysregulation can culminate in a relative
insulin-deficient state. Indirect evidence has recently accumulated for an enteric hormone (called a decretin)
that suppresses insulin and enhances glucagon output to promote T2D. A fundamental advance for the field
would be the identification of native hormones that normally regulate insulin and glucagon production and
secretion by pancreatic islet cells. We recently identified an enteroendocrine decretin signaling pathway in the
fruit fly Drosophila melanogaster regulated by nutrient availability, and essential for lipid, glucose and insulin
balance. We demonstrated from in vitro studies that the mammalian peptide hormone Neuromedin U (Nmu)
and its cognate G protein-coupled receptor, Nmu Receptor 1 (NmuR1) have similar functions. Nmu is
produced in enteroendocrine cells concentrated in the stomach, duodenum and ileum. In this proposal we
outline several original and novel approaches to investigate how the ligand-receptor pair Nmu/NmuR1 regulate
gastrointestinal hormone output.
To address these fundamental questions in both in mice and humans, we propose Specific Aims to: 1.
Assess the requirement for enteric Nmu in mouse metabolic homeostasis. 2. Decode Nmu signal transduction
mechanisms by G proteins and NmuR1 in pancreatic islets. 3. Identify mechanisms regulating NMU signaling
in human islets
This proposal is also notable for technical innovations in each Aim, including construction of multiple novel
mouse strains, and use of new ELISAs to investigate Nmu regulation in mice and humans. Collectively, these
state-of-the-art approaches will generate major new insights into the cellular and molecular mechanisms
controlling enteroendocrine regulation of metabolism in physiological settings. At a fundamental level, our work
should establish regulatory paradigms that interconnect metabolic signaling and regulation of crucial
gastrointestinal hormones. Thus, our work should have broad impact by suggesting strategies to diagnose,
stratify risk, and treat subsets of humans with diabetes mellitus or important pre-diabetic conditions like obesity
and impaired glucose tolerance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative and Biostatistics Core
-
批准号:10187128
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2021
-
负责人:Seung K Kim
-
依托单位:
Administrative and Biostatistics Core
-
批准号:10704093
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2021
-
负责人:Seung K Kim
-
依托单位:
Core C: CODEX Core
-
批准号:10704098
-
项目类别:
-
资助金额:$33.36万
-
财政年份:2021
-
负责人:Seung K Kim
-
依托单位:
Core C: CODEX Core
-
批准号:10456775
-
项目类别:
-
资助金额:$33.36万
-
财政年份:2021
-
负责人:Seung K Kim
-
依托单位:
Administrative and Biostatistics Core
-
批准号:10456772
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2021
-
负责人:Seung K Kim
-
依托单位:
In vivo systems to discover mechanisms regulating human islet alpha cell function
-
批准号:10623306
-
项目类别:
-
资助金额:$53.89万
-
财政年份:2020
-
负责人:Seung K Kim
-
依托单位:
In vivo systems to discover mechanisms regulating human islet alpha cell function
-
批准号:10228762
-
项目类别:
-
资助金额:$53.9万
-
财政年份:2020
-
负责人:Seung K Kim
-
依托单位:
In vivo systems to discover mechanisms regulating human islet alpha cell function
-
批准号:10441477
-
项目类别:
-
资助金额:$53.89万
-
财政年份:2020
-
负责人:Seung K Kim
-
依托单位:
Therapeutic targeting of human islets with recombinant regulatory T cells
-
批准号:10018894
-
项目类别:
-
资助金额:$73.56万
-
财政年份:2019
-
负责人:Seung K Kim
-
依托单位:
Therapeutic targeting of human islets with recombinant regulatory T cells
-
批准号:10450831
-
项目类别:
-
资助金额:$70.99万
-
财政年份:2019
-
负责人:Seung K Kim
-
依托单位:
Therapeutic targeting of human islets with recombinant regulatory T cells
-
批准号:9891726
-
项目类别:
-
资助金额:$76.3万
-
财政年份:2019
-
负责人:Seung K Kim
-
依托单位:
Therapeutic targeting of human islets with recombinant regulatory T cells
-
批准号:10238842
-
项目类别:
-
资助金额:$72.29万
-
财政年份:2019
-
负责人:Seung K Kim
-
依托单位:
Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humans
-
批准号:10376197
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2018
-
负责人:Seung K Kim
-
依托单位:
Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humans
-
批准号:9883793
-
项目类别:
-
资助金额:$39.51万
-
财政年份:2018
-
负责人:Seung K Kim
-
依托单位:
Administrative Core
-
批准号:10407862
-
项目类别:
-
资助金额:$37.07万
-
财政年份:2017
-
负责人:Seung K Kim
-
依托单位:
Reconstituting human pancreatic cancer development for translational research
-
批准号:9217005
-
项目类别:
-
资助金额:$51.56万
-
财政年份:2017
-
负责人:Seung K Kim
-
依托单位:
Stanford Diabetes Research Center
-
批准号:10668992
-
项目类别:
-
资助金额:$196.74万
-
财政年份:2017
-
负责人:Seung K Kim
-
依托单位:
Islet Procurement and Research Core
-
批准号:10197904
-
项目类别:
-
资助金额:$17.28万
-
财政年份:2017
-
负责人:Seung K Kim
-
依托单位:
Administrative Core
-
批准号:10197903
-
项目类别:
-
资助金额:$18.07万
-
财政年份:2017
-
负责人:Seung K Kim
-
依托单位:
Administrative Core
-
批准号:10668993
-
项目类别:
-
资助金额:$37.07万
-
财政年份:2017
-
负责人:Seung K Kim
-
依托单位:
海外基金